Home›Companies›Biotech & Pharma›Couragene

Couragene, Inc.

Updated Oct 27, 2026·Latest SEC filing May 22, 2024·Suggest an edit

About Couragene

Couragene is a private company based in Edison, New Jersey, incorporated in 2022 in Delaware. It has reported $3,600,000 raised in two offerings on Form D since September 2022.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 3, 2024May 22, 2024$1,000,000fully sold1$1.0MEquity, Series Seed III Preferred StockRule 506(b)Form D ↗
Aug 24, 2022Sep 6, 2022$2,600,000of $4.0M target7$371KEquity, Options, Securities on exercise, Series Seed I Preferred Stock and Series Seed II Preferred StockRule 506(b)Form D ↗
Total, two offerings$3,600,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Couragene's Form D filed May 22, 2024.

MH
GL
Guojuan Liao
Executive officer, director and promoter
JZ
JW
Jinlin Wang
Director

Sources

  1. SECCouragene, Inc. filing history